戻る Agenda
SESSION 3: Group Work – steps to take for preparedness in the UK and the EU
Speaker(s)
Vicki Edwards, RPH
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
Marketing Authorisation & Paediatric Investigation Plan & Clinical Trials
Steve Hoare
Association of the British Pharmaceutical Industry (ABPI), United Kingdom
Policy Director, Quality, Regulatory Science and Safety
Marketing Authorisation & Paediatric Investigation Plan & Clinical Trials
Kora H Doorduyn-van der Stoep, MSC, RPH
MEB, Netherlands
EU Representative